EUVIMEDEUVIMED entdecken
Crossref

A practical framework for clone selection, media‐feed screening, and upstream process parameter optimization for a mAb CHO cell culture process

Shreya Shah, Dhananajay Kumar, Aadesh Dhamdhere, Sonali Devi, Swapnali Patekar, Velu Mahalingam, Laxmi Adhikary, Viki Chopda iD

Biotechnology Progress · 2026

DOI: 10.1002/btpr.88503 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biotechnology Progress, 2026. Verfasst von Shreya Shah und 7 weiteren Autor:innen. Beteiligte Einrichtung: Upstream Process Development, R&D, Intas Pharmaceuticals Limited, Biopharma Division, Ahmedabad, Gujarat, India. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Cell Culture Techniques, Culture Media. Die Arbeit nennt 33 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study presents a data‐driven workflow for upstream process development in biologics manufacturing, aimed at improving consistency, efficiency, and decision‐making using established statistical and machine learning tools. Rather than relying on subjective interpretation, the framework integrates multiple analytical methods in a structured manner to support key process development decisions. For clone selection, K ‐means clustering was applied and benchmarked with hierarchical clustering to identify top‐performing candidates from a large clone pool. By incorporating multiple product quality attributes into the evaluation, the approach improves selection consistency and reduces subjectivity. In the media and feed screening stage, principal component analysis (PCA) was used to explore how specific combinations influence glycosylation patterns, enabling rapid identification of promising conditions for further optimization while reducing experimental burden. For upstream process parameter refinement, a sequential learning strategy based on multi‐objective Bayesian optimization (MOBO) was applied to adaptively explore trade‐offs among competing quality attributes and titer. This approach enabled more efficient identification of improved operating conditions compared with static experimental designs while minimizing experimental runs. While the methods used are well‐established, their structured integration into a cohesive workflow demonstrates practical utility for industrial applications. Aligned with Bioprocessing 4.0 principles, this approach supports improved process understanding and informed decision‐making in upstream bioprocess development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, MonoclonalCell Culture TechniquesCulture MediaAnimalsCHO CellsCricetulusBayes TheoremGlycosylationPrincipal Component AnalysisClustering AlgorithmsMachine LearningData AnalyticsCluster Analysis

Stichwörter der Autor:innen

Bayesian optimizationbioprocessing 4.0design of experimentsglycosylationmultivariate data analysis (MVDA)upstream process development

Substanzen

Antibodies, MonoclonalCulture Media

Autor:innen und Institutionen

  • Upstream Process Development, R&D, Intas Pharmaceuticals Limited, Biopharma Division, Ahmedabad, Gujarat, India.

ORCID-Profile: Viki Chopda

Zitieren

APA

Shah, S., Kumar, D., Dhamdhere, A., Devi, S., Patekar, S., Mahalingam, V., Adhikary, L., & Chopda, V. (2026). A practical framework for clone selection, media‐feed screening, and upstream process parameter optimization for a mAb CHO cell culture process. Biotechnology Progress. https://doi.org/10.1002/btpr.88503

Vancouver

Shah S, Kumar D, Dhamdhere A, Devi S, Patekar S, Mahalingam V, et al. A practical framework for clone selection, media‐feed screening, and upstream process parameter optimization for a mAb CHO cell culture process. Biotechnology Progress. 2026. doi:10.1002/btpr.88503

BibTeX
@article{Shah2026,
  author = {Shah, Shreya and Kumar, Dhananajay and Dhamdhere, Aadesh and Devi, Sonali and Patekar, Swapnali and Mahalingam, Velu and Adhikary, Laxmi and Chopda, Viki},
  title = {A practical framework for clone selection, media‐feed screening, and upstream process parameter optimization for a mAb CHO cell culture process},
  journal = {Biotechnology Progress},
  year = {2026},
  doi = {10.1002/btpr.88503}
}
Kostenlos starten →